Hedge funds are making some adjustments to their tech-investing playbook.
Goldman Sachs warned there's a risk of a 5% slump in US stocks because ... retreated after President Trump imposed an additional 10% tariff on Chinese goods. Moderna (MRNA) closed down more than -7% ...
Barclays downgraded shares of Moderna (NASDAQ:MRNA – Free Report) from an overweight rating to an equal weight rating in a report published on Tuesday, Ratings reports. The firm currently has $45.00 ...
China is starting to see a rebound in M&As as government stimulus measures start to bear fruit and pressure from Donald Trump ...
EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...
CSL and Cochlear are two of Australia’s blue-chip healthcare stocks, stalwarts of many investors portfolios, whereas Pro ...
Investors, shrugging off ongoing concerns around trade and inflation, are searching for the next catalyst to send stocks ...
Investors seeking to outperform the market should focus their stock-picking efforts on volatile names in the consumer ...
Please be advised, today's conference is being recorded. I would now like to hand the conference over to your speaker today, Lavina Talukdar. Please go ahead. Thank you, Kevin. Good morning, everyone, ...
Shares of Roku Inc (NASDAQ:ROKU) are up 14.5% in premarket trading, after the streaming giant shared smaller-than-expected ...
The company is now expecting 2025 revenue to range from $1.5 billion to $2.5 billion, with a midpoint of $2.0 billion, while FactSet is expecting $2.4 billion. Most of that will come in the second ...
U.S. stock futures were little changed on Thursday night after President Donald Trump held off on imposing new reciprocal ...